Disease Area Head (DAH) - Lung/GI/GU Oncology

Roche • South San Francisco, CA

2d

About The Position

Our Global Pharma Strategy (GPS) team plays a pivotal role in shaping the future of healthcare by driving the strategic direction of our innovative product portfolio. As a member of the GPS team, you will be at the forefront of transforming groundbreaking scientific discoveries into accessible and impactful healthcare solutions for patients worldwide. We are seeking a dynamic and visionary professional who thrives in a collaborative environment and is passionate about making a difference. As the Disease Area Head for Lung/GI/GU Cancers, you lead large-scale, multidisciplinary teams throughout the R&D path to value, composed of direct and indirect reports, with considerable influence on the company’s strategic, financial and operational performance. You will lead a team of senior leaders who are accountable for high quality strategic guidance for early pipeline decision making and leading lifecycle management in late stage; providing global, cross-functional leadership for research & development, technical, and commercialization activities for molecules/products across the Lung/GI/GU Cancer Disease Area. You are a standing member of the Oncology Therapeutic Area (TA) Leadership Team and make significant contributions to the long-range vision, strategy and plans for the TA and Roche Pharma overall. You will also be a standing member or co-lead various global governance committees, such as Business Boards and Development Boards. In this position, your responsibilities include: Lead large-scale multidisciplinary teams, composed of direct and indirect reports, with considerable influence on the Disease Area’s (DA) overall ambition and strategic, financial and operational performance. In collaboration with your team and cross-functional partners, you will make significant contributions to the 2030 Pharma vision as you shape the end-to-end Disease Area Strategies and plans. In partnership with the Research and Development organizations (Reds, PD), Business Development, Commercial Leadership Teams and Global Medical Affairs (PDMA), you and your team will shape the future portfolio for the DA and will lead global lifecycle management and development of all solutions (molecules/products) within the Disease Areas. You will have global responsibility for multiple molecules/products, which can include multiple line extensions. You will oversee a team of senior leaders who are accountable for coordinating and managing the lifecycle of late-stage and on-market products; providing global, cross-functional leadership for all Research & development, technical, manufacturing, and commercial activities. Co-leading the Lung/GI/GU Cancer Disease Area Team that develops and implements long-term end-to-end Roche strategy in the assigned Disease Areas. In partnership with the functions mentioned above, leading development and execution of a robust, integrated and cohesive end-to-end vision and strategy for the overall franchise, which includes individual global lifecycle strategies and plans for all products/indications across the assigned franchise. Developing and managing the Lung/GI/GU Cancer Disease Area budget to ensure financial targets are met and to optimize resource allocation Contribute to shape the external Disease Area ecosystem, engaging with the world’s most renowned Therapeutic Area Experts, Patients’ Advisory Groups, Healthcare industry leaders, Biotech.

Requirements

• Extensive experience in the pharmaceutical/biotechnology industry, with development and therapeutic area experience in the relevant Disease Area.
• Outstanding people leader and developer in a multicultural environment and virtual set-up, with demonstrated ability to lead business and people through high impact change and transformation.
• Experience leading large cross-functional organizations, preferably in the domains of drugs research and development, drugs and indications pre-launch and launch, throughout the entire cycle of strategy setting and execution.
• Deep understanding and knowledge of the Disease Area competitive landscape, and experience in partnering with business development/acquisitions teams.
• Outstanding partnership skills: with a track record that includes finding opportunities that have improved results in areas beyond direct management or influence.
• Confirmed abilities to work effectively in multicultural, matrix environments, across numerous time zones.
• Education: Master's degree.
• Required to travel globally approx 30% of the time.
• Working language: English.

Nice To Haves

• MD, PhD or MBA are strongly preferred.

Responsibilities

• Lead large-scale multidisciplinary teams, composed of direct and indirect reports, with considerable influence on the Disease Area’s (DA) overall ambition and strategic, financial and operational performance.
• In collaboration with your team and cross-functional partners, you will make significant contributions to the 2030 Pharma vision as you shape the end-to-end Disease Area Strategies and plans.
• In partnership with the Research and Development organizations (Reds, PD), Business Development, Commercial Leadership Teams and Global Medical Affairs (PDMA), you and your team will shape the future portfolio for the DA and will lead global lifecycle management and development of all solutions (molecules/products) within the Disease Areas.
• You will have global responsibility for multiple molecules/products, which can include multiple line extensions.
• You will oversee a team of senior leaders who are accountable for coordinating and managing the lifecycle of late-stage and on-market products; providing global, cross-functional leadership for all Research & development, technical, manufacturing, and commercial activities.
• Co-leading the Lung/GI/GU Cancer Disease Area Team that develops and implements long-term end-to-end Roche strategy in the assigned Disease Areas.
• In partnership with the functions mentioned above, leading development and execution of a robust, integrated and cohesive end-to-end vision and strategy for the overall franchise, which includes individual global lifecycle strategies and plans for all products/indications across the assigned franchise.
• Developing and managing the Lung/GI/GU Cancer Disease Area budget to ensure financial targets are met and to optimize resource allocation
• Contribute to shape the external Disease Area ecosystem, engaging with the world’s most renowned Therapeutic Area Experts, Patients’ Advisory Groups, Healthcare industry leaders, Biotech.

What This Job Offers

• Job Type: Full-time
• Career Level: Executive
• Number of Employees: 5,001-10,000 employees